ASHM Webcast & Video Podcast of the 21st Annual Conference of the Australasian Society for HIV Medicine powered by - MULTIWEBCAST

21st Annual Conference of the Australasian Society for HIV Medicine

LIST OF PRESENTATIONS/COURSES

ABOUT THIS COURSE

OTHER WEBCASTS

Webcasted Presentations

BROWSE:

ALL PRESENTATIONS/COURSES

SPEAKERS

ACCREDITED COURSES

PPT SLIDES

VIDEO PODCASTS

Use this index to quickly access speakers by name.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Scroll down to see presentations grouped by speakers.

Judith Auerbach
	Addressing Social Drivers of HIV/AIDS 2009-09-09 - English available!

Judith Auerbach
	HIV Prevention for Gay Men in the U.S. 2009-09-11 - English available!

Leon Botes
	High levels of user acceptability and cytological abnormalities in self collected anal swabs among HIV-infected men who have sex with men in Sydney 2009-09-10 - English

Andrew Carr
	Cardiovascular Disease - How Should it Affect Antiretroviral Therapy? 2009-09-10 - English

Chris Chiu
	Using photographed HIV rapid tests in a pilot EQAS 2009-09-11 - English

Mark Connors
	Qualitative features of an effective immune response to HIV 2009-09-11 - English

David Cooper
	Introduction to "A Lifetime of HIV/AIDS" and abstract themes 2009-09-09 - English

Lucette Cysique
	A screening algorithm for HIV associated neurocognitive disorders 2009-09-10 - English

Steve Deeks
	Immunologic aging: Are antiretroviral treated patients aging too fast and if so why? 2009-09-10 - English

Steve Deeks
	The changing nature of antiretroviral treatment failure 2009-09-10 - English

Fraser Drummond
	Markers of inflammation, coagulation and renal function in HIV-infected adults in smart and in two large population-based studies, Cardia and Mesa 2009-09-10 - English

Vicki Edouard
	The adaptation of the low cost Cavidi Exavir(TM) load RT assay for use with dried plasma spots to measure HIV-1 viral load in resource limited settings 2009-09-11 - English

Sean Emery
	Effect of recombinant interleukin-2 (IL-2) on clinical outcomes in patients with a CD4+ T-cell count of >300/mm3: Primary results of the ESPRIT study 2009-09-09 - English

Sean Emery
	Immune-based therapies for HIV infection: where might this be heading now? 2009-09-11 - English

Michelle Giles
	Practical issues in prescribing antiretrovirals in pregnancy and in women who may become pregnant 2009-09-11 - English

Andrew Grulich
	HPV-associated cancers in immune deficient populations 2009-09-09 - English

Imelda Hanafi
	Lack of correlation at the lower limit of detection of three commercially available viral load assays for the quantitation of HIV-1 RNA 2009-09-11 - English

David Harrich
	Arginine methylation increases the stability of HIV-1 tat 2009-09-10 - English available!

Anna Hearps
	The use of dried blood spots for HIV-1 drug resistance testing within resource limited settings 2009-09-11 - English

Anna Hearps
	An HIV-1 integrase genotyping assay for the detection of drug resistance mutations 2009-09-11 - English

Mark Kelly
	A study of aldesleukin with and without antiretroviral therapy (STALWART): What we've learnt 2009-09-09 - English

Michael Kidd
	Call to action, new strategies 2009-09-11 - English available!

Matthew Law
	Combined analysis of the primary results of the evaluation of proleukin in a randomised international study (ESPRIT) and subcutaneous recombinant, human interleukin-2 in HIV-infected patients with low CD4+ counts under active antiretroviral therapy (SILCA 2009-09-09 - English available!

Sharon Lewin
	Understanding HIV latency and strategies for HIV eradication 2009-09-10 - English

Enmoore Lin
	Predictors of initial episode bacterial Pneumonia in ESPRIT 2009-09-10 - English

Kathy Petoumenos
	Predicting the short term risk of diabetes in HIV infected patients: the D:A:D study group 2009-09-10 - English

Sarah Pett
	Effect of recombinant interleukin-2 (IL-2) on clinical outcomes in patients with CD4+ T-cell count 50 to 299/mm3: Primary results of the SILCAAT study 2009-09-09 - English

Rebekah Puls
	Safety and efficacy of three different combination antiretroviral regimens as initial therapy for HIV infection: week 48 data from a randomised, open-label study 2009-09-09 - English

Reena Rajasuriar
	Biological determinants of immune reconstitution following highly-active antiretroviral therapy (HAART) 2009-09-09 - English

Kiat Ruxrungtham
	Immune Responses in Co-infection 2009-09-11 - English

Georgina Sallman
	CCL19 leads to enhanced nuclear import of HIV in resting CD4+ T-cells: a path to establishing latent HIV infection in vivo 2009-09-10 - English

Endang R. Sedyaningsih
	Women selling sex in Indonesia: struggle for life 2009-09-10 - English available!

Peter Siba
	A Lifetime of HIV in Papua New Guinea: 1986 to Today 2009-09-11 - English

Ajantha Solomon
	No decay in HIV-infected naïve CD4+T-cells following antiretroviral therapy (ART): A persistent long term reservoir 2009-09-09 - English

Kazuo Suzuki
	Retroviral delivery of promoter-targeted shRNA induces profound, specific, long-term silencing of HIV-1 transcription 2009-09-10 - English available!

E. Tippett
	Tetrapanins in monocytes and macrophages and their role in HIV-1 infection 2009-09-10 - English

Kylie Warren
	Cellular factors and the regulation of HIV-1 replication 2009-09-10 - English available!

Fiona Wightman
	The novel HDAC inhibitors Metacept-(MCT)-1 and MCT-3 have potent activity on HIV-1 transcription in latently infected cells 2009-09-10 - English

Use this index to quickly access speakers by name.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Disclaimer ^{AMENDED ON January 29, 2009} | Technical Support

USER ACKNOWLEDGES AND AGREES THAT ALL DECISIONS MADE WITH THE ASSISTANCE OR USE OF THE SOFTWARE AND/OR THE WEBSITE AND/OR BASED ON CONTENT FOUND HEREIN WILL BE EXCLUSIVELY THE RESPONSIBILITY OF THE USER.

Search’n Build™